相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sex Differences in Diabetic Kidney Disease
Christine Maric-Bilkan
MAYO CLINIC PROCEEDINGS (2020)
Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
Debra Dorotea et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy
Min Lei et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes
Cristiano P. Vieira et al.
JCI INSIGHT (2020)
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease
Sandra Rayego-Mateos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
Agha Zeeshan Mirza et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction
Shen Li et al.
FASEB JOURNAL (2019)
Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease
Jia Fu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury
Wei Zhu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Co-targeting of endothelin-A and vitamin D receptors: a novel strategy to ameliorate cisplatin-induced nephrotoxicity
Lobna M. Abdel Moneim et al.
PHARMACOLOGICAL REPORTS (2019)
Identification of New Small Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation
Lijie Peng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
PGC-1α, a potential therapeutic target against kidney aging
Gayoung Lee et al.
AGING CELL (2019)
Src-mediated crosstalk between FXR and YAP protects against renal fibrosis
Dong-Hyun Kim et al.
FASEB JOURNAL (2019)
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Agnes Nemeth et al.
BMC NEPHROLOGY (2019)
Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism
Xiaofang Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Vitamin D attenuates gentamicin-induced acute renal damage via prevention of oxidative stress and DNA damage
M. A. Mohammed et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2019)
Sex-Related Disparities in CKD Progression
Ana C. Ricardo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Advantages of Single-Nucleus over Single-Cell RNA Sequencing of Adult Kidney: Rare Cell Types and Novel Cell States Revealed in Fibrosis
Haojia Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis
Tzu-Ming Jao et al.
KIDNEY INTERNATIONAL (2019)
Vitamin D testing and treatment: a narrative review of current evidence
Stefan Pilz et al.
ENDOCRINE CONNECTIONS (2019)
Potential role of estradiol in ovariectomy-induced derangement of renal endocrine functions
Ahmed A. El-Gendy et al.
RENAL FAILURE (2019)
Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis
Jie Du et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Estrogen-related receptor-α mediates puromycin aminonucleoside-induced mesangial cell apoptosis and inflammatory injury
Wei Gong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
The PGC-1/ERR network and its role in precision oncology
Humberto De Vitto et al.
NPJ PRECISION ONCOLOGY (2019)
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Xiaoxin X. Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Estrogen-related receptor alpha is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury
Keigo Tsushida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway
Nicholas S. Kirkby et al.
HYPERTENSION (2018)
Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma
Patricia Corrales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy
Habib Yaribeygi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Endoplasmic reticulum stress in the pathogenesis of fibrotic disease
Jonathan A. Kropski et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Perilipin-2 deletion promotes carbohydrate-mediated browning of white adipose tissue at ambient temperature
Andrew E. Libby et al.
JOURNAL OF LIPID RESEARCH (2018)
Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease
Juanjuan Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages
Evan D. Muse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism
Ryohei Kaseda et al.
BMC NEPHROLOGY (2018)
Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition
Nashwa Eltablawy et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
Wenshan Lv et al.
FRONTIERS IN PHYSIOLOGY (2018)
Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury
Jin-Bo Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice
Inbal Dahan et al.
JOURNAL OF DIABETES RESEARCH (2018)
PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus
Li Zheng et al.
JOURNAL OF DIABETES RESEARCH (2018)
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
Ivan Casaburi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Liver X receptors link lipid metabolism and inflammation
Ira G. Schulman
FEBS LETTERS (2017)
Activation of Peroxisome Proliferator Activator Receptor / Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus
Miguel Romero et al.
HYPERTENSION (2017)
A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
Xiaoxin X. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Vanessa Dubois et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids
Diego Scerbo et al.
JOURNAL OF LIPID RESEARCH (2017)
Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update
Tianxin Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
Andi Marquardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Ligands of Therapeutic Utility for the Liver X Receptors
Rajesh Komati et al.
MOLECULES (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
Barbara Toffoli et al.
PLOS ONE (2017)
MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy
Zhanmei Zhou et al.
CELL DEATH & DISEASE (2017)
The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research
Rebecca Wafer et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
Zhibo Gai et al.
SCIENTIFIC REPORTS (2017)
VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway
Jia Guo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The protective role of vitamin D on the heart and the kidney
Walter Manucha et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)
Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats
Margaret A. Zimmerman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice
Zhibo Gai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN
Carole Henique et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
Stefano Ballestri et al.
ADVANCES IN THERAPY (2016)
Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins
Natarajan Balasubramaniyan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei Wei et al.
CELL METABOLISM (2016)
Pioglitazone, a Peroxisome Proliferator-Activated Receptor gamma Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model
Li Sun et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis
Rui Cheng et al.
DIABETES (2016)
Estrogen-related receptor (ERR) γ protects against puromycin aminonucleoside-induced podocyte apoptosis by targeting PI3K/Akt signaling
Wei Gong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome
Andrew E. Libby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy
Akari Inada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
LXR agonist T0901317 upregulates thrombomodulin expression in glomerular endothelial cells by inhibition of nuclear factor-κB
Hanlu Ding et al.
MOLECULAR MEDICINE REPORTS (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Computational investigation of the interaction mechanism between the estrogen related receptor α and its agonists
Fuxing Li et al.
RSC ADVANCES (2016)
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Kai Zhao et al.
SCIENTIFIC REPORTS (2016)
RAS and sex differences in diabetic nephropathy
Sergi Clotet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy
Bo Zheng et al.
KIDNEY INTERNATIONAL REPORTS (2016)
In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway
Hang Wang et al.
ENDOCRINE (2016)
Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease
Janice M. Huss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The liver X receptor agonist TO901317 protects mice against cisplatin-induced kidney injury
Meng Yang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
Subha Madhavan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Estrogen-related receptors in breast cancer and prostate cancer
Aya Misawa et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases
Etienne Audet-Walsh et al.
ACTA PHARMACOLOGICA SINICA (2015)
A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
Dong-Hyun Kim et al.
EMBO JOURNAL (2015)
Estrogen directly and specifically downregulates NaPi-IIa through the activation of both estrogen receptor isoforms (ERα and ERβ) in rat kidney proximal tubule
Dara Burris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Action mechanisms of Liver X Receptors
Chiara Gabbi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals
Ting Bai et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice
Monika Patel et al.
DIABETOLOGIA (2014)
Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway
Dal Kim et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
Bogna Grygiel-Gorniak
NUTRITION JOURNAL (2014)
Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines
Daisuke Ogawa et al.
PLOS ONE (2014)
Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner
Eun Hui Bae et al.
PLOS ONE (2014)
Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
Xiaoyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The many faces of estrogen signaling
Peter Vrtacnik et al.
BIOCHEMIA MEDICA (2014)
Lipid Droplet Accumulation Is Associated with an Increase in Hyperglycemia-Induced Renal Damage Prevention by Liver X Receptors
Eva Kiss et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Altered Unfolded Protein Response Is Implicated in the Age-Related Exacerbation of Proteinuria-Induced Proximal Tubular Cell Damage
Naoko Takeda et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
Yan-Ming Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation
Massimo Collino et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia
Larisa V. Fedorova et al.
PLOS ONE (2013)
PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
Alejandra V. Contreras et al.
ADVANCES IN NUTRITION (2013)
Activation of liver X receptors reduces CFTR-mediated Cl- transport in kidney collecting duct cells
Promporn Raksaseri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney
Hyun Ae Lim et al.
BIOGERONTOLOGY (2012)
Iristectorigenin B isolated from Belamcanda chinensis is a liver X receptor modulator that increases ABCA1 and ABCG1 expression in macrophage RAW 264.7 cells
Hee-jin Jun et al.
BIOTECHNOLOGY LETTERS (2012)
Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice
M. Gonzalez-Granillo et al.
DIABETOLOGIA (2012)
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
Claudia Tovar-Palacio et al.
GENES AND NUTRITION (2012)
Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy
Hiromi Tachibana et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
The Corepressor NCoR1 Antagonizes PGC-1α and Estrogen-Related Receptor α in the Regulation of Skeletal Muscle Function and Oxidative Metabolism
Joaqun Perez-Schindler et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Taurine is a liver X receptor-α ligand and activates transcription of key genes in the reverse cholesterol transport without inducing hepatic lipogenesis
Minh-Hien Hoang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
Anna C. Calkin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Peroxisome proliferator-activated receptor- activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in Type 2 diabetes
Eun Young Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Age-Associated Molecular Changes in the Kidney in Aged Mice
Ji Hee Lim et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Expression Profile of Nuclear Receptors along Male Mouse Nephron Segments Reveals a Link between ERRβ and Thick Ascending Limb Function
Halla Krid et al.
PLOS ONE (2012)
Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease
Yu-bing Dai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Nuclear receptors in renal disease
Moshe Levi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
Yuichi Matsushita et al.
DIABETES (2011)
Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice
Yao-Jen Liang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats
Massimo Collino et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters
Yupanqui A. Caldas et al.
KIDNEY INTERNATIONAL (2011)
GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
Xu Yang et al.
PLOS ONE (2011)
Fasting Induces the Expression of PGC-1α and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney
Christina T. Teng et al.
PLOS ONE (2011)
Peroxisome Proliferator-Activated Receptor-alpha Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension
Dexter L. Lee et al.
PPAR RESEARCH (2011)
Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism
Xiaoxin X. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Estrogens and Progression of Diabetic Kidney Damage
Sophie Doublier et al.
CURRENT DIABETES REVIEWS (2011)
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2011)
Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats
Michaele B. Manigrasso et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Renal lipid metabolism and lipotoxicity
Ion Alexandru Bobulescu
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
Xiaoxin X. Wang et al.
DIABETES (2010)
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy
Lingyun Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation
Ichiaki Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mechanistic connection between inflammation and fibrosis
Soo Bong Lee et al.
KIDNEY INTERNATIONAL (2010)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw et al.
LANCET (2010)
ERRγ Regulates Cardiac, Gastric, and Renal Potassium Homeostasis
William A. Alaynick et al.
MOLECULAR ENDOCRINOLOGY (2010)
Physiological Genomics Identifies Estrogen-Related Receptor alpha as a Regulator of Renal Sodium and Potassium Homeostasis and the Renin-Angiotensin Pathway
Annie M. Tremblay et al.
MOLECULAR ENDOCRINOLOGY (2010)
Nuclear hormone receptors in diabetic nephropathy
Xiaoxin X. Wang et al.
NATURE REVIEWS NEPHROLOGY (2010)
Role of PPARαand Its Agonist in Renal Diseases
Ching-Feng Cheng et al.
PPAR Research (2010)
Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells
Yu Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Peroxisome proliferator-activated receptor-α activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats
Seok Joon Shin et al.
HYPERTENSION RESEARCH (2009)
The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
Hai-Chun Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat
Pitchai Balakumar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria
Xiaoxin X. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate
Frank M. Sacks
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells
Xi Chen et al.
CELL (2008)
Vascular PPARγ Controls Circadian Variation in Blood Pressure and Heart Rate through Bmal1
Ningning Wang et al.
CELL METABOLISM (2008)
Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors
Cynthia Hong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Estrogen receptors in the kidney: Lessons from genetically altered mice
Pascale H. Lane
GENDER MEDICINE (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
Liver X Receptor: A Novel Therapeutic Target
M. B. Patel et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Mathis Grossmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Klotho is a target gene of PPAR-gamma
Hong Zhang et al.
KIDNEY INTERNATIONAL (2008)
PPARα:: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
Frank J. Gonzalez et al.
TOXICOLOGY (2008)
PPARs and the kidney in metabolic syndrome
Xiongzhong Ruan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release
Yu-Jung Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE
Michelle N. Bradley et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor α
Darja Debevec et al.
MOLECULAR ENDOCRINOLOGY (2007)
T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR
Nico Mitro et al.
FEBS LETTERS (2007)
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
Sakiko Ohga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy
Alexis Dixon et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation
Tonghuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
P. A. Sarafidis et al.
KIDNEY INTERNATIONAL (2006)
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes
Gregory Proctor et al.
DIABETES (2006)
PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse
Anna C. Calkin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis
H-C Yang et al.
KIDNEY INTERNATIONAL (2006)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
CW Park et al.
KIDNEY INTERNATIONAL (2006)
Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1
Lu-Lu Chen et al.
VASCULAR PHARMACOLOGY (2006)
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor α
CW Park et al.
DIABETES (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine
H Lee et al.
JOURNAL OF LIPID RESEARCH (2006)
Kidney-specific gene targeting: Insight into thiazolidinedione-induced fluid retention
Tianxin Yang
NEPHROLOGY (2006)
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway
T Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
S Ogawa et al.
CELL (2005)
Peroxisome proliferator-activated receptor β/δ exerts a strong protection from ischemic acute renal failure
E Letavernier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention
H Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of the liver X receptor α and β in embryonic and adult mice
JS Annicotte et al.
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2004)
PPARα ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity
SY Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor α
BB Busch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Liver X receptor-α mediates cholesterol efflux in glomerular mesangial cells
J Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
PPAR-α ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G
SY Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy
LH Cheng et al.
NATURE MEDICINE (2004)
Highly elevated serum phyto-oestrogen concentrations in patients with diabetic nephropathy
L von Hertzen et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Peroxisome proliferator-activated receptor δ controls muscle development and oxydative capability
S Luquet et al.
FASEB JOURNAL (2003)
Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist
E Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Global transcription profiling of estrogen activity: Estrogen receptor a regulates gene expression in the kidney
SA Jelinsky et al.
ENDOCRINOLOGY (2003)
The liver X receptor gene team: Potential new players in atherosclerosis
JJ Repa et al.
NATURE MEDICINE (2002)
Microarray analyses during adipogenesis:: Understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism
SE Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus
LJ Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation
F Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Role of peroxisome proliferator-activated receptor-α in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding
MC Sugden et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure
D Portilla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
JJ Repa et al.
SCIENCE (2000)
分享论文
